Brixy Pharmaceuticals

Hyderabad, India Founded: 2018 • Age: 8 yrs
Manufacturer of generic drugs

About Brixy Pharmaceuticals

Brixy Pharmaceuticals is a Healthcare company based in Hyderabad (India) founded in 2018. Manufacturer of generic drugs. It operates on a Traditional Pharmaceuticals model. Its Indian entity Brixy Pharmaceuticals Private Limited reported revenue of β‚Ή30.7 Lakh. Brixy Pharmaceuticals offers products and services including Brixy Pharmaceuticals Platform. Its focus areas include Traditional Pharmaceuticals, Generics, Companies and Diversified.

Company details

Brixy Pharmaceuticals, established in 2018, excels in providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. Manufacturer of generic drugs. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.

Key Metrics
  • Annual Revenue
    ₹30.7 Lakh

    FY 2019

  • Net Profit
    ₹28,636

    FY 2019 · 1% margin

  • EBITDA
    ₹93,822

    FY 2019 · 3% margin

Products & Services of Brixy Pharmaceuticals

Brixy Pharmaceuticals offers a comprehensive portfolio of products and services, including Brixy Pharmaceuticals Platform.

Brixy Pharmaceuticals Platform
Healthcare

Manufacturer of generic drugs

Board of directors of Brixy Pharmaceuticals Private Limited (Brixy Pharmaceuticals)

Brixy Pharmaceuticals Private Limited is the primary company behind Brixy Pharmaceuticals. The board of Brixy Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Lavanya Kondabathula, appointed in 2018.

DirectorDesignationAppointedTenureEntity
Lavanya Kondabathula
DIN 08032970
Director09 Jan 20188 yrs 10 moBrixy Pharmaceuticals Private Limited
Sridhar Kondabathula
DIN 08032961
Director09 Jan 20188 yrs 10 moBrixy Pharmaceuticals Private Limited

Financials of Brixy Pharmaceuticals

Figures of Brixy Pharmaceuticals Private Limited, the primary company behind Brixy Pharmaceuticals, for FY 2019. Revenue was ₹30.7 Lakh. Net profit was ₹28,636 (1% margin). EBITDA was ₹93,822 (3% margin).

  • ₹30.7 LakhRevenue · FY 2019
  • ₹28,636Net profit · 1% margin
  • ₹93,822EBITDA · 3% margin
  • ₹1 LakhPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Brixy Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Brixy Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Brixy Pharmaceuticals

Brixy Pharmaceuticals was founded in 2018.

Brixy Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

The primary company behind Brixy Pharmaceuticals, Brixy Pharmaceuticals Private Limited, reported revenue of β‚Ή30.7 Lakh for FY 2019.

Brixy Pharmaceuticals, established in 2018, excels in providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. Manufacturer of generic drugs. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.

Brixy Pharmaceuticals offers Brixy Pharmaceuticals Platform.

Brixy Pharmaceuticals operates through Brixy Pharmaceuticals Private Limited.

The legal entities of Brixy Pharmaceuticals currently have 2 directors, including Lavanya Kondabathula, Sridhar Kondabathula.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available